Global Cardioverter Defibrillator Device market

Cardioverter Defibrillator Device Market Size, Share, Growth Analysis, By Type (Implantable Cardioverter Defibrillators, External Cardioverter Defibrillators), By End Use (Hospitals, Pre-Hospital), By Region - Industry Forecast 2026-2033

Report ID: SQMIG35A2207 | Region: Global | Published Date: December, 2024
Pages: 224 |Tables: 64 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Cardioverter Defibrillator Device Market size was valued at USD 16.17 Billion in 2024 and is poised to grow from USD 17.32 Billion in 2025 to USD 29.98 Billion by 2033, growing at a CAGR of 7.1% during the forecast period (2026–2033). 

    Global cardioverter defibrillator devices market is highly competitive. Implantable cardioverter defibrillator key market players are Medtronic PLC, Abbott Laboratories, and Boston Scientific Corporation. Koninklijke Philips N.V., Cardiac Science Corporation, and Zoll Medical Corporation are leading the external defibrillator market. Key players undergo mergers and acquisitions to produce innovative products. They also focus on strengthening their position in the global market. 'Medtronic PLC ', 'Abbott Laboratories ', 'Boston Scientific Corporation ', 'BIOTRONIK SE & Co. KG ', 'LivaNova PLC ', 'Stryker Corporation ', 'Koninklijke Philips N.V. ', 'Cardiac Science Corporation ', 'Zoll Medical Corporation ', 'Nihon Kohden Corporation ', 'Schiller AG ', 'Fukuda Denshi Co. ', 'Mediana Co., Ltd. ', 'Defibtech LLC ', 'Physio-Control (Stryker Corporation) '

    Defibrillators have improved in terms of cost, size reduction, and ease of operation. The advancement in technology is as follows- automated external defibrillator (AED) and implantable cardioverter defibrillator (ICD). These devices are effective in controlling cardiac attack conditions. Due to technological advancements in defibrillators, the operating defibrillator has become easy for an observer post-induction of proper training.

    Smart Pacemaker to Elevate Market Demand: Smart pacemaker is a device that can detect even the smallest irregularity in the functioning of the heart. Smart pacemakers rectify the abnormalities in the heart and re-establish normal body function. It also alerts the patients as well as physicians about the patient's cardiac health. This feature of the smart pacemaker helps to decrease the mortality rate.

    North America is expected to hold the largest market share during the forecast period due to initiatives taken by key players, favorable regulations, and advanced technological facilities in the U.S and Canada.

    Related Reports

    Defibrillator Market
    Buy Now GET FREE SAMPLE
    External Defibrillators Market
    Buy Now GET FREE SAMPLE
    Automated External Defibrillators Market
    Buy Now GET FREE SAMPLE
    Heart Pump Device Market
    Buy Now GET FREE SAMPLE
    Cardiac Rhythm Management Devices Market
    Buy Now GET FREE SAMPLE
    Cardiac Monitoring and Cardiac Rhythm Management Devices Market
    Buy Now GET FREE SAMPLE
    Cardiac Assist Devices Market
    Buy Now GET FREE SAMPLE
    Cardiovascular Devices Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Cardioverter Defibrillator Device market

    Report ID: SQMIG35A2207

    $5,300
    BUY NOW